# Evidence of survival bias in the association between APOE-Є4 and age at ischemic stroke onset

**Authors:** Joanna von Berg, Patrick F. McArdle, Paavo Häppölä, Jeffrey Haessler, Charles Kooperberg, Robin Lemmens, Alessandro Pezzini, Vincent Thijs, Sara L. Pulit, Steven J. Kittner, Braxton D. Mitchell, Jeroen de Ridder, Sander W. van der Laan

PMC · DOI: 10.3389/fgene.2024.1392061 · 2024-09-02

## TL;DR

This study suggests that a genetic variant linked to earlier stroke onset may actually reflect survival bias rather than a direct effect on stroke risk.

## Contribution

The paper introduces a novel hypothesis that the APOE-Є4 allele's association with stroke age at onset may be due to survival bias, not direct stroke causation.

## Key findings

- The APOE-Є4 allele is associated with a 1.29-year earlier age at onset of ischemic stroke in women.
- Simulations suggest that the observed effect could result from survival bias due to higher mortality in non-carriers.
- The association may not reflect a direct causal relationship with stroke but rather a general survival effect.

## Abstract

Large genome-wide association studies (GWASs) using case–control study designs have now identified tens of loci associated with ischemic stroke (IS). As a complement to these studies, we performed GWAS in a case-only design to identify loci influencing the age at onset (AAO) of ischemic stroke.

Analyses were conducted in a discovery cohort of 10,857 ischemic stroke cases using a linear regression framework. We meta-analyzed all SNPs with p-value <1 x 10−5 in a sexcombined or sex-stratified analysis using summary data from two additional replication cohorts.

In the women-only meta-analysis, we detected significant evidence for the association of AAO with rs429358, an exonic variant in apolipoprotein E (APOE) that encodes for the APOE-Є4 allele. Each copy of the rs429358:T>C allele was associated with a 1.29-year earlier stroke AAO (meta p-value = 2.48 x 10−11). This APOE variant has previously been associated with increased mortality and ischemic stroke AAO. We hypothesized that the association with AAO may reflect a survival bias attributable to an age-related decrease in mortality among APOE-Є4 carriers and have no association to stroke AAO per se. A simulation study showed that a variant associated with overall mortality might indeed be detected with an AAO analysis. A variant with a 2-fold increase in mortality risk would lead to an observed effect of AAO that is comparable to what we found.

In conclusion, we detected a robust association of the APOE locus with stroke AAO and provided simulations to suggest that this association may be unrelated to ischemic stroke per se but related to a general survival bias.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348]
- **Diseases:** ischemic stroke (MONDO:1060198)

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}
- **Diseases:** stroke (MESH:D020521), IS (MESH:D002544)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T>C, rs429358

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11403718/full.md

---
Source: https://tomesphere.com/paper/PMC11403718